These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8903661)

  • 41. A comparison of the effect of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism on the structural changes associated with hypertension in rat small arteries.
    Shaw LM; George PR; Oldham AA; Heagerty AM
    J Hypertens; 1995 Oct; 13(10):1135-43. PubMed ID: 8586805
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of lacidipine on the carotid and cerebral circulations in essential hypertension.
    Safar ME
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S51-4. PubMed ID: 1726008
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Calcium antagonism: aldosterone and vascular responses to catecholamines and angiotensin II in man.
    Elliott HL
    J Hypertens Suppl; 1993 Dec; 11(6):S13-6. PubMed ID: 8169376
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Spontaneous vasomotion in pressurized cerebral arteries from genetically hypertensive rats.
    Osol G; Halpern W
    Am J Physiol; 1988 Jan; 254(1 Pt 2):H28-33. PubMed ID: 3337256
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Calcium antagonists as a new treatment modality in hypertension.
    Laragh JH
    Angiology; 1988 Jan; 39(1 Pt 2):100-5. PubMed ID: 3277491
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of factors in hypertension: change of membrane fluidity in the arteries of spontaneously hypertensive and monocrotaline-injected rats.
    Takeshita M; Yoshida S; Miyata M; Yoshida H
    Clin Exp Pharmacol Physiol Suppl; 1992; 20():33-5. PubMed ID: 1446407
    [TBL] [Abstract][Full Text] [Related]  

  • 47. No persistent effect of angiotensin converting enzyme inhibitor treatment in Milan hypertensive rats despite regression of vascular structure.
    Mulvany MJ; Persson AE; Andresen J
    J Hypertens; 1991 Jul; 9(7):589-93. PubMed ID: 1653793
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Urinary kallikrein excretion and blood pressure response to angiotensin converting enzyme inhibitors and calcium antagonists in hypertensive patients.
    Dessì-Fulgheri P; Espinosa E; Zingaretti O; Guazzarotti F; Sarzani R; Pupita G; Sturbini S; Catalini R; Rappelli A
    J Hypertens; 1993 Jul; 11(7):725-30. PubMed ID: 8228191
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of antihypertensive drug therapy on the morphology and mechanics of resistance arteries from spontaneously hypertensive rats.
    Warshaw DM; Root DT; Halpern W
    Blood Vessels; 1980; 17(5):257-70. PubMed ID: 7397409
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resistance and conduit arteries following converting enzyme inhibition in hypertension.
    Safar ME; van Bortel LM; Struijker-Boudier HA
    J Vasc Res; 1997; 34(2):67-81. PubMed ID: 9167639
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Angiotensin converting enzyme inhibition improves cardiac neuronal uptake of noradrenaline in spontaneously hypertensive rats.
    Raasch W; Betge S; Dendorfer A; Bartels T; Dominiak P
    J Hypertens; 2001 Oct; 19(10):1827-33. PubMed ID: 11593103
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Arterial stiffness and hypertension: emerging concepts.
    Payne RA; Wilkinson IB; Webb DJ
    Hypertension; 2010 Jan; 55(1):9-14. PubMed ID: 19948990
    [No Abstract]   [Full Text] [Related]  

  • 53. Long-term therapeutic effects of ace inhibitor and calcium antagonists on hypertensive vascular lesions in M-SHRSP.
    Ohta Y; Chikugo T; Suzuki T
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S321-2. PubMed ID: 9072411
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential modulation of baroreceptor sensitivity by long-term antihypertensive treatment.
    Ichikawa M; Suzuki H; Kumagai K; Kumagai H; Ryuzaki M; Nishizawa M; Saruta T
    Hypertension; 1995 Sep; 26(3):425-31. PubMed ID: 7649577
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Arterial structural modifications in hypertension. Effects of treatment.
    Thom S
    Eur Heart J; 1997 Nov; 18 Suppl E():E2-4. PubMed ID: 9402464
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Experimental basis of the long-term therapy of arterial hypertension with calcium antagonists.
    Fleckenstein A; Frey M; Zorn J; Fleckenstein-Grün G
    Am J Cardiol; 1985 Dec; 56(16):3H-14H. PubMed ID: 2416214
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The central nervous system and effective antihypertensive effects of a calcium channel blocker.
    Takahashi H; Yoshimura M
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S129-33. PubMed ID: 2455113
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Calcium antagonists in hypertensive disease: experimental evidence for a new therapeutic concept.
    Kazda S; Garthoff B; Luckhaus G
    Postgrad Med J; 1983; 59 Suppl 2():78-83. PubMed ID: 6351044
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical aspects of parathyroid hypertensive factor.
    Lewanczuk RZ; Benishin CG; Shan J; Pang PK
    J Cardiovasc Pharmacol; 1994; 23 Suppl 2():S23-6. PubMed ID: 7518541
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hemodynamic effects of calcium entry-blocking agents in normal and hypertensive rats and man.
    Frohlich ED
    Am J Cardiol; 1985 Dec; 56(16):21H-27H. PubMed ID: 2933949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.